Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Winningham Rick E
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,686,408    

Indirect Shares

  96,467      
Direct Value   $32,443,553    

Indirect Value

  $950,200      
Total Shares   2,782,875      
Total Value   $33,393,753      


Innoviva Inc
 $13,074,193 Jazz Pharmaceuticals Inc
 $1,141,216 Theravance Biopharma, Inc.
 $18,228,144 Innoviva Inc
 $13,074,193 Jazz Pharmaceuticals Inc
 $1,141,216 Theravance Biopharma, Inc.
 $18,228,144
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -15.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Innoviva Inc INVA Director 2014-08-15 825,391 2008-01-29 0    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 10,444 2012-01-11 0    Premium*  
            Theravance Biopharma, Inc. TBPH 2024-04-02 1,850,573 2024-04-02 96,467    Premium*  
* Premium Members only  

Records found :    130         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-20 4 D $8.92 $331,788 D/D (37,196) 1,558,769 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 A $8.64 $23,363 D/D 2,704 1,561,473 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 GD $0.00 $0 D/D 10,900 1,550,573 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-03-15 4 GA $0.00 $0 I/I 3,900 3,900 0 -
TBPH Theravance Biopharma, Inc... CHIEF EXECUTIVE OFFICER   •       •      –    2024-04-02 4 A $0.00 $0 D/D 300,000 1,850,573 0 -

  130  Records found
  1   2   3   4   5   6     
  Page 6 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed